Novo Nordisk said it would limit the supply of starter doses of Wegovy as demand outpaces the company's manufacturing capacity. The supply interruptions aren't expected to affect higher doses of the medicine for people who already take the drug. Novo Nordisk said it anticipates that many people will have trouble filling prescriptions at the lower initial doses through September, according to CNN.